Aquabattery CEO, Jiajun Cen and Statkraft EVP International, Ingeborg Dårflot.
COP28: Statkraft and Aquabattery partner to develop flow batteries made with salt water
05 déc. 2023 05h37 HE | Statkraft AS
(Dubai/Oslo/Delft, 5 December 2023) Norwegian renewables company Statkraft and Dutch climate tech start-up Aquabattery partner to develop a promising technology to improve long-term storage of...
Mendus_Red.png
Mendus AB: Mendus erhåller slutbetalning som ett resultat av EU Horizon 2020 AML-VACCiN-projektets slutförande
12 oct. 2022 02h00 HE | Mendus AB
HORIZON 2020 BEVILJADE STÖD FÖR MENDUS ATT ETABLERA ETT STARKT EUROPEISKT FORSKNINGS- OCH KLINISKT NÄTVERK FÖR UTVECKLING AV DCP-001 I AML   Mendus AB (“Mendus” publ; IMMU.ST), ett...
Mendus_Red.png
Mendus AB: Mendus to receive final payment as a result of the completion of the EU Horizon 2020 AML-VACCiN project
12 oct. 2022 02h00 HE | Mendus AB
HORIZON 2020 GRANT SUPPORTED MENDUS IN ESTABLISHING A STRONG EUROPEAN RESEARCH AND CLINICAL NETWORK FOR THE DEVELOPMENT OF DCP-001 IN AML   Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical...
Presentation of 2022 Holland on the Hill Heineken Award
Merck Recognized for Responsible Entrepreneurship in the Netherlands
19 mai 2022 15h39 HE | Embassy of the Kingdom of the Netherlands
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New Jersey-based...
Immunicum meddelar l
Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer
22 févr. 2021 02h00 HE | Immunicum AB
Pressmeddelande 22 februari 2021 Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer - Medianöverlevnad för patientgruppen som behandlades...
Immunicum Announces
Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer
22 févr. 2021 02h00 HE | Immunicum AB
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer -- Median Overall Survival (OS) for the...
Immunicum AB (publ)
Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna
27 janv. 2021 02h00 HE | Immunicum AB
27 januari 2021 Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna Immunicum AB (publ; IMMU.ST) meddelar idag att de...
Immunicum AB (publ)
Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands
27 janv. 2021 02h00 HE | Immunicum AB
Press Release 27 January 2021  Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands Immunicum AB (publ; IMMU.ST) announced today that...
Bart van Eijck
ValueSelling Associates Welcomes Sales Industry Expert Bart van Eijck
17 sept. 2020 14h50 HE | ValueSelling Associates, Inc.
RANCHO SANTA FE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- ValueSelling Associates, Inc. announces its partnership with Bart van Eijck to expand the reach of ValueSelling’s sales training and sales...
Dutch Embassy Recognizes the Rosie the Riveter with "A Ringing Tribute to Honor the Rosies"
03 sept. 2020 17h12 HE | Embassy of the Kingdom of the Netherlands
Washington, D.C., Sept. 03, 2020 (GLOBE NEWSWIRE) -- As the Kingdom of the Netherlands commemorates the end of World War II and celebrates 75 years of freedom, the Dutch Embassy today recognized...